Adverse event reporting
This article was originally published in The Tan Sheet
Executive Summary
FDA publishes in the Jan. 27 Federal Register a proposed regulation pre-empting state or local laws that allow disclosure to patients or reporters of adverse events associated with FDA- regulated products. Commissioner David Kessler announced the upcoming regs Jan. 21 ("The Tan Sheet" Jan. 24. p. 3)